Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JAGN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARHGEF9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUPV3L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF692 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3R4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF621 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PARL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLJ20021 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TROVE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL32P3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRPRB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HYLS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAT10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SREBF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on